Greiner, Jochen http://orcid.org/0000-0003-1256-173X
Götz, Marlies
Hofmann, Susanne
Schrezenmeier, Hubert
Wiesneth, Markus
Bullinger, Lars
Döhner, Hartmut
Schneider, Vanessa
Funding for this research was provided by:
Bristol-Myers Squibb (CA184-397)
Deutsche Forschungsgemeinschaft (SFB 1074 project B3)
Article History
Received: 26 April 2019
Accepted: 18 January 2020
First Online: 4 February 2020
Compliance with ethical standards
:
: J. Greiner received funds from BMS (Bristol-Myers Squibb); the other authors do not have any competing interests with regard to this study.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Registration details: University of Ulm, approval number 221/14, date 20.10.2014 and approval number 334/09, date 08.02.2010 and Ethics Committee Landesärztekammer Baden-Württemberg, date of approval 21.11.2014, approval file number B-F-2014-105 221/14.
: Informed consent was obtained in writing before specimen was taken from all individuals participating in the study. Patients and healthy donors consented to the use of their specimen and data for research and for publication.
: Cell lines were purchased from the DSMZ (German Collection of Microorganisms and Cell Cultures GmbH) and were authenticated: OCI-AML-2 (DSMZ ACC 099), full-matching STR reference profile of OCI-AML-2, authentic; OCI-AML-3 (DSMZ ACC 582), full-matching STR reference profile of OCI-AML-3, authentic.